pubmed-article:19297248 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19297248 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:19297248 | lifeskim:mentions | umls-concept:C0038454 | lld:lifeskim |
pubmed-article:19297248 | lifeskim:mentions | umls-concept:C0000970 | lld:lifeskim |
pubmed-article:19297248 | lifeskim:mentions | umls-concept:C0070924 | lld:lifeskim |
pubmed-article:19297248 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
pubmed-article:19297248 | lifeskim:mentions | umls-concept:C1698947 | lld:lifeskim |
pubmed-article:19297248 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19297248 | pubmed:dateCreated | 2009-4-20 | lld:pubmed |
pubmed-article:19297248 | pubmed:abstractText | High body temperature in the first 12-24 h after stroke onset is associated with poor functional outcome. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial aimed to assess whether early treatment with paracetamol improves functional outcome in patients with acute stroke by reducing body temperature and preventing fever. | lld:pubmed |
pubmed-article:19297248 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19297248 | pubmed:language | eng | lld:pubmed |
pubmed-article:19297248 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19297248 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19297248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19297248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19297248 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19297248 | pubmed:month | May | lld:pubmed |
pubmed-article:19297248 | pubmed:issn | 1474-4422 | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:RamA BAB | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:KoudstaalPete... | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:van GijnJanJ | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:AlgraAleA | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:KappelleL... | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:DippelDiederi... | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:van der... | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:van GemertH... | lld:pubmed |
pubmed-article:19297248 | pubmed:author | pubmed-author:den... | lld:pubmed |
pubmed-article:19297248 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19297248 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:19297248 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19297248 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19297248 | pubmed:pagination | 434-40 | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:meshHeading | pubmed-meshheading:19297248... | lld:pubmed |
pubmed-article:19297248 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19297248 | pubmed:articleTitle | The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. | lld:pubmed |
pubmed-article:19297248 | pubmed:affiliation | Department of Neurology, Erasmus MC University Medical Centre, Rotterdam, Netherlands. m.denhertog@erasmusmc.nl | lld:pubmed |
pubmed-article:19297248 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19297248 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:19297248 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19297248 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:19297248 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19297248 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19297248 | lld:pubmed |